Skip to content

Go/No-Go Intervention for Weight Loss

The Effect of Go/No-Go Training Dosage on Weight Loss, Food Evaluation, and Disinhibition in Overweight and Obese Individuals: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04624087
Enrollment
78
Registered
2020-11-10
Start date
2020-10-19
Completion date
2021-11-01
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Brief summary

The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.

Detailed description

Within the current obesogenic environment, the prevalence of overweight and obesity has dramatically increased over the past 40 years. As a result, approximately 40% of Americans attest to being on a diet, with most of these efforts being unsuccessful. Most weight loss diets rely on self-control and reflective thinking (e.g., making conscious food choices multiple times per day), despite the fact that responses to appetitive foods often occur through implicit (unconscious) processes. The proposed study is a randomized clinical trial for weight loss that targets these implicit processes through the use of a computerized, food-specific, go/no-go task. This task has previously resulted in reduced food consumption in laboratory settings, and small but significant weight loss in two brief intervention studies. The purpose of this study is to replicate one prior study and to compare different doses of the intervention. Participants will be assigned to one of three groups: high intensity, low intensity, or active control, and will be assessed on a number of variables pre- and post-intervention. Changes in body weight, food evaluation, frequency of self-reported food consumption, and eating disinhibition scores will be evaluated. It is hypothesized that individuals receiving the food-specific go/no-go training (high intensity and low intensity groups) will experience greater weight loss, decreased disinhibition with food, and reduced snacking of the targeted foods than those in the active control group. It is also hypothesized that the high intensity intervention will be more effective than the low intensity intervention across these variables. Moderators (e.g., dietary restraint, disinhibition) will also be explored throughout this study, along with the mechanism of devaluation of specific foods.

Interventions

BEHAVIORALfood-specific go/no-go computerized training

Participants will perform the computerized food specific go/no-go training a designated number of times over a four week duration (frequency varies by group). Each training session will last approximately 10 minutes and occur on different days of the week.

BEHAVIORALnonfood-specific go/no-go computerized training

Participants will perform the computerized general go/no-go training 1 time per week over a four week duration. Each training session will last approximately 10 minutes and occur on different days of the week.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body Mass Index (BMI) ≥ 25 * Age ≥ 18 * Consume some of the determined no-go snack foods at least three times per week (assessed using a food frequency questionnaire) * A desire to lose weight

Exclusion criteria

* Medical condition limiting dietary intake * Medical condition directly affecting weight * Current use of weight loss medication * Actively enrolled in a formal weight loss program currently or within the past 6 months (e.g., Weight Watchers) * History of bariatric surgery * Currently pregnant * Current smoker * Smoking cessation within the past year

Design outcomes

Primary

MeasureTime frameDescription
Change in body weight from baseline to post 4-week intervention, to 6-month follow-upbaseline, post 4-week intervention, 6-month follow-upBody weight will be measured by participant using personal or university scale. Participants will take a picture of their weight send it to the research team (Due to COVID-19 precautions, in person weighing is not possible).
Change in disinhibition scores from baseline to post 4-week intervention, to 6-month follow-up.baseline, post 4-week intervention, 6-month follow-upThis will be measured using the Disinhibition subscale of the Three Factor Eating Questionnaire; minimum value = 0; maximum value = 16; higher scores for this measure means worse outcomes
Change in frequency of food consumption from baseline to post 4-week intervention, to 6-month follow-up.baseline, post 4-week intervention, 6-month follow-upThis will be measured using a food frequency questionnaire assessing food intake over the previous month.

Secondary

MeasureTime frameDescription
Change in binge eating behaviors from baseline to post 4-week intervention, to 6-month follow-up.baseline, post 4-week intervention, 6-month follow-upThis will be measured using the binge eating questions of the Eating Disorder Examination Questionnaire; minimum value = 0; maximum value = unlimited; higher scores for this measure means worse outcomes
Change in liking of foods from baseline to post 4-week intervention, to 6-monthbaseline, post 4-week intervention, 6-month follow-upThis will be measured using a visual analog scale; minimum value = -100; maximum value = 100; higher scores for this measure on healthy foods means better outcomes, higher scores on this measure for unhealthy foods means worse outcomes
Change in automatic responses to healthy and unhealthy foods from baseline to post 4-week intervention, to 6-monthbaseline, post 4-week intervention, 6-month follow-upThis will be measured using an impulsive food choice test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026